EDGAR Filing Documents for 0001193125-09-041018

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-09-041018

Filing Date

2009-02-27

Accepted

2009-02-27 16:27:22

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d20f.htm	20-F	1855441
2	FIRST AMENDMENT TO CREDIT AGREEMENT, DATED AS OF OCTOBER 24, 2006	dex222.htm	EX-2.22	44132
3	SECOND AMENDMENT TO CREDIT AGREEMENT, DATED AS OF OCTOBER 27, 2008	dex223.htm	EX-2.23	170474
4	GUARANTY, DATED AS OF DECEMBER 23, 2008	dex224.htm	EX-2.24	42009
5	FIRST AMENDMENT TO CREDIT AGREEMENT, DATED AS OF OCTOBER 27, 2008	dex226.htm	EX-2.26	90353
6	GUARANTY, DATED AS OF DECEMBER 23, 2008	dex227.htm	EX-2.27	41831
7	AGREEMENT AND PLAN OF MERGER, DATED AS OF JANUARY 22, 2008	dex41.htm	EX-4.1	259286
8	SUBSIDIARIES OF THE REGISTRANT	dex8.htm	EX-8	15929
9	CONSENT OF KESSELMAN & KESSELMAN	dex10.htm	EX-10	2406
10	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex12i.htm	EX-12.(I)	9188
11	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex12ii.htm	EX-12.(II)	9174
12	CERTIFICATION OF THE CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	dex13.htm	EX-13	4642
13	GRAPHIC	g93445ex2_23pg023a.jpg	GRAPHIC	5633
14	GRAPHIC	g93445ex2_23pg055c.jpg	GRAPHIC	6193
15	GRAPHIC	g93445ex2_26pg010initial.jpg	GRAPHIC	1588
16	GRAPHIC	g93445ex2_26pg015a.jpg	GRAPHIC	5633
	Complete submission text file	0001193125-09-041018.txt		2573207

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)